Liang Liu

发表

Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry

Zi-feng Yang, Sookja K. Chung, Sami Hamdoun, 2021, Pharmacological Research.

Discovery of novel urea-based hepatitis C protease inhibitors with high potency against protease-inhibitor-resistant mutants.

R. Hamatake, Suoming Zhang, S. Baker, 2012, Journal of medicinal chemistry.

Inhibition of Toll-Like Receptor-Mediated Inflammation In Vitro and In Vivo by a Novel Benzoxaborole

K. Jarnagin, A. Gertrudes, T. Akama, 2013, Journal of Pharmacology and Experimental Therapeutics.

Discovery and structure-activity relationships of 6-(benzoylamino)benzoxaboroles as orally active anti-inflammatory agents.

K. Jarnagin, M. Orr, J. Plattner, 2013, Bioorganic & medicinal chemistry letters.

Benzoxaborole antimalarial agents. Part 3: design and syntheses of (carboxy‐13C‐3,3‐2H2)‐labeled and (3‐14C)‐labeled 7‐(2‐carboxyethyl)‐1,3‐dihydro‐1‐hydroxy‐2,1‐benzoxaboroles

J. Plattner, Yong-Kang Zhang, Liang Liu, 2012 .

Synthesis of new acylsulfamoyl benzoxaboroles as potent inhibitors of HCV NS3 protease.

Z. Ni, Suoming Zhang, S. Baker, 2010, Bioorganic & medicinal chemistry letters.

Synthesis and biological evaluations of P4-benzoxaborole-substituted macrocyclic inhibitors of HCV NS3 protease.

Z. Ni, Suoming Zhang, S. Baker, 2010, Bioorganic & medicinal chemistry letters.

Analysis of monofluoroacetic acid in human plasma by UFLC–MS/MS and its application in patients with sodium monofluoroacetate or monofluoroacetamide poisoning

S. Zhai, X. Hai, Liang Liu, 2018, Journal of pharmaceutical and biomedical analysis.

Synthesis and SAR of acyclic HCV NS3 protease inhibitors with novel P4-benzoxaborole moieties.

Z. Ni, Suoming Zhang, S. Baker, 2011, Bioorganic & medicinal chemistry letters.

Inhibition of Toll-Like Receptor-Mediated Inflammation in vitro and in vivo by a Novel Benzoxaborole

K. Jarnagin, A. Gertrudes, T. Akama, 2012 .

Linking Phenotype to Kinase: Identification of a Novel Benzoxaborole Hinge-Binding Motif for Kinase Inhibition and Development of High-Potency Rho Kinase Inhibitors

K. Jarnagin, F. Rock, Yong-Kang Zhang, 2013, The Journal of Pharmacology and Experimental Therapeutics.

Early rapid identification of in vivo rat metabolites of AN6414, a novel boron-containing PDE4 inhibitor by QTRAP LC/MS/MS to support drug discovery.

K. Jarnagin, V. Ciaravino, T. Akama, 2012, Journal of pharmaceutical and biomedical analysis.

The novel sensitive and high throughput determination of cefepime in mouse plasma by SCX-LC/MS/MS method following off-line microElution 96-well solid-phase extraction to support systemic antibiotic programs.

Liang Liu, Xiaoqing Fan, Wei Bu, 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase

Christopher B. Cooper, Lisa K. Woolhiser, J. Sacchettini, 2016, Antimicrobial Agents and Chemotherapy.

Structure-activity relationships of 6-(aminomethylphenoxy)-benzoxaborole derivatives as anti-inflammatory agent.

K. Jarnagin, J. Nieman, Rajeshwar Singh, 2013, Bioorganic & medicinal chemistry letters.

Discovery of a Novel Class of Boron-Based Antibacterials with Activity against Gram-Negative Bacteria

J. Nieman, S. Cusack, D. Livermore, 2013, Antimicrobial Agents and Chemotherapy.

with Activity against Gram-negative Bacteria

J. Nieman, S. Cusack, D. Livermore, 2013 .

Linking Phenotype to Kinase: Identification of a Novel Benzoxaborole Hinge-Binding Motif for Kinase Inhibition and Development of High-Potency Rho Kinase Inhibitors

K. Jarnagin, F. Rock, Yong-Kang Zhang, 2013, The Journal of Pharmacology and Experimental Therapeutics.